Caricamento...
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review
Blau syndrome (BS) is an autoinflammatory disorder characterized by non-caseating granulomatous dermatitis, arthritis, and uveitis. We present a case of refractory and severe BS that was treated with the Janus kinase inhibitors (JAKINIBS), Tofacitinib (TOFA) and then Baricitinib (BARI). Our aim was...
Salvato in:
| Autori principali: | , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publishing
2022-04-01
|
| Serie: | Therapeutic Advances in Musculoskeletal Disease |
| Accesso online: | https://doi.org/10.1177/1759720X221093211 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|